Our Team

Jonathan Appleby, Ph.D.

Alliance and Project Leader

Jonathan Appleby joined the ceedd in 2006 and currently manages alliances with European and emerging-market companies covering therapy areas such as oncology, neurology, respiratory and anti-infectives. Dr. Appleby's Genetics Ph.D. from the University of Leeds was complemented by a year's post-doctoral research with the Cancer Research Campaign in Manchester. In 1996 he moved from the benchside in order to gain experience of clinical pharmacology with Quintiles Phase I unit in London (QGUY) and from there moved to GlaxoWellcome in 1999. After the merger with SmithKlineBeecham, Dr. Appleby took a prominent position leading several drug discovery programs in neurology. Dr. Appleby is currently working with the ceedd alliance Ranbaxy.

• ‹‹ Previous
• Back to List
• Next ››